Influence of pathogens on host genome and epigenome in development of head and neck cancer
- PMID: 37322598
- PMCID: PMC10644332
- DOI: 10.1002/cnr2.1846
Influence of pathogens on host genome and epigenome in development of head and neck cancer
Abstract
Background: Head and neck cancer (HNSCC) is a heterogeneous group of cancers, affecting multiple regions such as oral cavity, pharynx, larynx, and nasal region, each showing a distinct molecular profile. HNSCC accounts for more than 6 million cases worldwide, soaring mainly in the developing countries.
Recent findings: The aetiology of HNSCC is complex and multifactorial, involving both genetic and environmental factors. The critical role of microbiome, which includes bacteria, viruses, and fungi, is under spotlight due to the recent reports on their contribution in the development and progression of HNSCC. This review focuses on the effect of opportunistic pathogens on the host genome and epigenome, which contributes to the disease progression. Drawing parallels from the host-pathogen interactions observed in other tumour types arising from the epithelial tissue such as colorectal cancer, the review also calls attention to the potential explorations of the role of pathogens in HNSCC biology and discusses the clinical implications of microbiome research in detection and treatment of HNSCC.
Conclusion: Our understanding of the genomic effects of the microbes on the disease progression and the mechanistic insights of the host-pathogen interaction will pave way to novel treatment and preventive approaches in HNSCC.
Keywords: cancer associated pathogens; head and neck cancer; host-pathogen interaction.
© 2023 The Author. Cancer Reports published by Wiley Periodicals LLC.
Conflict of interest statement
The author declare that they have no competing interest.
Figures

Similar articles
-
Towards system genetics analysis of head and neck squamous cell carcinoma using the mouse model, cellular platform, and clinical human data.Animal Model Exp Med. 2023 Dec;6(6):537-558. doi: 10.1002/ame2.12367. Epub 2023 Dec 21. Animal Model Exp Med. 2023. PMID: 38129938 Free PMC article. Review.
-
Role of Vitamin D in Head and Neck Cancer-Immune Function, Anti-Tumour Effect, and Its Impact on Patient Prognosis.Nutrients. 2023 May 31;15(11):2592. doi: 10.3390/nu15112592. Nutrients. 2023. PMID: 37299554 Free PMC article. Review.
-
UBE2C promotes the progression of head and neck squamous cell carcinoma.Biochem Biophys Res Commun. 2020 Mar 5;523(2):389-397. doi: 10.1016/j.bbrc.2019.12.064. Epub 2019 Dec 20. Biochem Biophys Res Commun. 2020. PMID: 31870550
-
Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas.Cells. 2019 Apr 21;8(4):366. doi: 10.3390/cells8040366. Cells. 2019. PMID: 31010087 Free PMC article.
-
Harnessing the role of epigenetic histone modification in targeting head and neck squamous cell carcinoma.Epigenomics. 2022 Mar;14(5):279-293. doi: 10.2217/epi-2020-0348. Epub 2022 Feb 21. Epigenomics. 2022. PMID: 35184601 Review.
Cited by
-
Deciphering the impacts of gut and tissue microbiome on human cancers.Cancer Rep (Hoboken). 2023 Nov;6(11):e1924. doi: 10.1002/cnr2.1924. Cancer Rep (Hoboken). 2023. PMID: 37962007 Free PMC article. No abstract available.
-
Intratumoral Fusobacterium nucleatum is associated with better cancer-specific survival in head and neck cancer patients.J Oral Microbiol. 2025 Apr 1;17(1):2487644. doi: 10.1080/20002297.2025.2487644. eCollection 2025. J Oral Microbiol. 2025. PMID: 40182114 Free PMC article.
References
-
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209‐249. - PubMed
-
- Hashibe M, Hunt J, Wei M, Buys S, Gren L, Lee Y‐CA. Tobacco, alcohol, body mass index, physical activity, and the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian (PLCO) cohort. Head Neck. 2013;35(7):914‐922. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical